Nikhil Chopra - MEDI ASSIST Chief Officer
| MEDIASSIST | 568.65 16.80 2.87% |
Executive
Nikhil Chopra is Chief Officer of MEDI ASSIST HEALTHCARE
| Address | Tower D, Bengaluru, India, 560029 |
| Phone | 91 80 6919 0000 |
| Web | https://www.mediassist.in |
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Basavraj Loni | Fino Payments Bank | N/A | |
| P Sudharshan | Mangalore Chemicals Fertilizers | N/A | |
| Pravin Chavan | Indo Borax Chemicals | N/A | |
| Vijay Kumar | Alkali Metals Limited | 73 | |
| Tejas Maniar | Fino Payments Bank | N/A | |
| Ankur Jain | India Glycols Limited | 49 | |
| Haritha Varanasi | KNR Constructions Limited | N/A | |
| Liuwei He | Kingfa Science Technology | 49 | |
| Vaikuntanathan | KNR Constructions Limited | 70 | |
| Ankur Singhai | Mahindra Logistics Limited | N/A | |
| Shailesh Pandey | Fino Payments Bank | N/A | |
| Saurabh Taneja | Mahindra Logistics Limited | N/A | |
| Ketan Merchant | Fino Payments Bank | N/A | |
| Edwin Lobo | Mahindra Logistics Limited | N/A | |
| Major Thomas | Fino Payments Bank | N/A | |
| Sreeram Venkateswaran | Mahindra Logistics Limited | N/A | |
| Narasimha Ramana | KNR Constructions Limited | 61 | |
| Rakesh Kumar | India Glycols Limited | N/A | |
| Bhaskar Rao | KNR Constructions Limited | 57 | |
| Sun Yajie | Kingfa Science Technology | N/A | |
| Srikantha | Mangalore Chemicals Fertilizers | N/A | |
MEDI ASSIST HEALTHCARE Leadership Team
Elected by the shareholders, the MEDI ASSIST's board of directors comprises two types of representatives: MEDI ASSIST inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MEDI. The board's role is to monitor MEDI ASSIST's management team and ensure that shareholders' interests are well served. MEDI ASSIST's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MEDI ASSIST's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Satish Gidugu, CEO Director | ||
| Manish Vij, Senior Head | ||
| Vijay Sankaran, Senior CMO | ||
| Nicholas Taylor, Chief Care | ||
| Abhishek Pandey, SVP Head | ||
| Prashant Shrivastava, Senior Resources | ||
| Mathew George, Chief Officer | ||
| Manmohan Kalsy, President HR | ||
| Simmi Bisht, Chief Secretary | ||
| Shivani Burman, Senior Head | ||
| Anuj Jindal, Senior Network | ||
| Dhruv Rastogi, Senior Science | ||
| Sandeep Daga, Chief Officer | ||
| Himanshu Rastogi, Chief Officer | ||
| Vikram MD, Chairman | ||
| Nikhil Chopra, Chief Officer | ||
| Niraj Didwania, Corporate MA | ||
| Azaz Shaikh, Senior Partnerships | ||
| Shubhra Singh, Senior Solutions | ||
| Varun Kansal, Senior Management | ||
| Praveen Samariya, Senior Engineering |
MEDI Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MEDI ASSIST a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Profit Margin | 0.10 % | ||||
| Operating Margin | 0.13 % | ||||
| Current Valuation | 38.06 B | ||||
| Shares Outstanding | 70.5 M | ||||
| Shares Owned By Insiders | 9.07 % | ||||
| Shares Owned By Institutions | 71.65 % | ||||
| Price To Book | 8.45 X | ||||
| Price To Sales | 5.90 X | ||||
| Revenue | 6.35 B | ||||
| EBITDA | 1.31 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for MEDI Stock Analysis
When running MEDI ASSIST's price analysis, check to measure MEDI ASSIST's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEDI ASSIST is operating at the current time. Most of MEDI ASSIST's value examination focuses on studying past and present price action to predict the probability of MEDI ASSIST's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEDI ASSIST's price. Additionally, you may evaluate how the addition of MEDI ASSIST to your portfolios can decrease your overall portfolio volatility.